Trial to Evaluate the Effects of Sound Modulation on Critically Ill Patients
NCT ID: NCT03019133
Last Updated: 2025-04-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
120 participants
INTERVENTIONAL
2016-12-31
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Impact of Receptive Music Therapy in the ICU
NCT03931733
Assessing the Impact of LIve Music in the Intensive Care Unit (ICU) to Improve Care for Critically Ill Patients
NCT03948984
Music as a Complement to Pharmacological Sedation in Ventilator Treated ICU Patients.
NCT05602662
Music Therapy is Associated With Decreased Pain and Agitation in Intubated ICU Patients
NCT01316536
Medical Use of Song In Critical Care (MUSIC)
NCT01763736
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The investigators plan to study the effect of noise masking and noise reduction on stress related physiological parameters in critically ill patients admitted to the ICU. Subjects will be randomized into 3 separate groups: control, noise reduction, and noise masking. The investigators will compare the heart rate and blood pressure variability between and within the groups to determine the effects of treatment assignment on these variables. Non-invasive measurements obtained from the bedside monitor will be collected using physiological data acquisition software.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Usual Care
Usual care will be provided.
No interventions assigned to this group
Sound reduction
Use of noise reduction headphones. Pro For Sho safety ear muffs with a noise reduction rate of 34dB will be used.
Sound reduction
Subjects will wear noise reduction headphones between the hours of 8:00 pm and 8:00 am.
Sound masking
Use of headphones and relaxing music. Sennheiser HD 280 pro headphones will be used for sound masking.
Sound masking
Subjects will wear wear headphones playing relaxing music between the hours of 8:00 pm and 8:00 am.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sound reduction
Subjects will wear noise reduction headphones between the hours of 8:00 pm and 8:00 am.
Sound masking
Subjects will wear wear headphones playing relaxing music between the hours of 8:00 pm and 8:00 am.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Untreated sleep apnea disorder, narcolepsy, REM sleep behavior disorder, parasomnia, restless leg syndrome or other sleep disorder
* Use of hearing aids, or known significant conductive or sensory hearing loss
* Ventilator support via an endotracheal tube
* Use of vasopressors
* Unresponsive or delirious
* Subjects with known Dementia, Parkinson's disease, or other neurodegenerative disorder
* Subjects with a pacemaker or who have received cardiac transplant
18 Years
99 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Brian Gehlbach
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Brian Gehlbach
Clinical Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Brian K Gehlbach, MD
Role: PRINCIPAL_INVESTIGATOR
Faculty
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Iowa Hospitals and Clinics
Iowa City, Iowa, United States
Countries
Review the countries where the study has at least one active or historical site.
Study Documents
Access uploaded study-related documents such as protocols, statistical analysis plans, or lay summaries.
Document Type: Informed Consent Form
View DocumentOther Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
201609843
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.